Abstract
Fibrin deposition in the interstitial space of the stroma of malignant tumours is a frequent finding (see reviews by Rickles and Edwards 1983; Dvorak et al. 1983) and can be regularly observed, among others, in lymph nodes with Hodgkin’s disease (Harris et al. 1982). Hypotheses based on supporting experimental and clinical data implicate intratumoral fibrin in the promotion of tumour growth and metastasis formation (Laki 1974; Dvorak et al. 1983). Fibrin may serve as a barrier making tumour cells relatively inaccessible for the host’s immune response, may play an important role in tumour angiogenesis and desmoplasia and might support the implantation of tumour cells at metastatic sites.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ádány R, Belkin A, Vasilevskaya T, Muszbek L (1985) Identification of blood coagulation factor XIII in human peritoneal mcrophages. Eur J Cell Biol 38:171–173
Ádány R, Nemes Z, Muszbek L (1987a) Characterization of factor XIII containing-macrophages in lymph nodes with Hodgkin’s disease. Br. J Cancer 55:421–42
Ádány R, Kappelmayer J, Muszbek L (1987b) Expression of FXIII subunit a in different types of human macrophages. In: Mauri C, Rizzo SC, Ricevuti G (eds) The biology of phagocytes in health and disease, Pergamon, Oxford
Ádàny R, Kiss A, Muszbek L (1987c) Factor XIII: a marker of mono-and megakariocytopoiesis. Br J Haematol 67:167–172
Ádány R, Glukhova MA, Kabakov AY, Muszbek L (1988) Characterization of human connective tissue cells containing factor XIII subunit a. J Clin Pathol, (in press)
Aoki N, Harpel PC (1984) Inhibitors of the fibrinolytic enzyme system. Semin Thromb Hemost 10:24–41
Beck E, Duckert F, Ernst M (1961) The influence of fibrin stabilizing factor on the growth of fibroblasts in vitro and wound healing. Thromb Diath Haemorrh 6:485–491
Bruhn HD (1981) Growth regulation of vessel wall cells and of tumor cells by thrombin, factor XIII and fibronectin. Thromb Haemost 46:762
Bruhn HD, Pohl J (1981) Growth regulation of fibroblasts by thrombin, factor XIII and fibronectin. Klin Wochenschr 59:141–146
Bruhn HD, Zurborn KH (1983) Influences of clotting factors (thrombin, factor XIII) and of fibronectin on the growth of tumor cells and leukemic cells in vitro. Blut 46:85–88
Curatolo L, Colucci M, Cambini AL, Poggi A, Morasca L, Donati MB, Semeraro N (1979) Evidence that cells from experimental tumours can activate coagulant factor X. Br J Cancer 40:228–233
Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skirer L (1985) Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 44:139–266
Dimitriu-Bona A, Burmester GR, Waters SJ, Winchester RJ (1983) Human mononuclear phagocyte differentiation antigens. I. Patterns of antigenic expression on the surface of human monocytes and mcrophages defined by monoclonal antibodies. J Immunol 130:145–152
Duffy MJ, O’Grady PO (1984) Plasminogen activator and cancer. Eur J Cancer Clin Oncol 20:577–582
Dvorak AM, Connell AB, Proppe K, Dvorak HF (1978) Immunologic rejection of mammary adenocarcinoma (TA3-St) in C57BL/6 mice: participation of neutrophils and activated macrophages with fibrin formation. J Immunol 120:1240–1248
Dvorak HF, Senger DR, Dvorak AM (1983) Fibrin as a component of the tumor stroma: origins and biological significance. Cancer Metastasis Rev 2:41–73
Dvorak HF, Harvey S, McDonagh J (1984) Quantitation of fibrinogen influx and fibrin deposition and turnover in line 1 and line 10 quinea pig carcinomas. Cancer Res 44:3348–3354
Edwards RL, Rickles FR, Cronlund M (1981) Abnormalities of blood coagulation in patients with cancer: mononuclear cell tissue factor generation. J Lab Clin Med 98:917–928
Gordon ST (1981) A proteolytic procoagulant associated with malignant transformation. J Histochem Cytochem 29:457–463
Gordon ST, Franks JJ, Lewis B (1975) Cancer procoagulant A: a factor X activating procoagulant from malignant tissue. Thromb Res 6:127–137
Guarini A, Acero R, Alessio G, Donati MB, Semeraro N, Mantovani A (1984) Procoagulant activity of macrophages associated with different murine neoplasms. Int J Cancer 34:581–586
Harris NL, Dvorak AM, Smith J, Dvorak HF (1982) Fibrin deposits in Hodgkin’s disease. Am J Pathol 108:119–129
Henriksson P, Becker S, Lynch G, McDonagh J (1985) Identification of factor XIII in human monocytes and macrophages. J Clin Invest 76:528–534
Israels ED, Paraskevas F, Israels LG (1973) Immunological studies of coagulation factor XIII. J Clin Invest 52:2398–2403
Jansen JWCM, Haverkate F, Koopman J, Nieuwenhuis HK, Kluft C, Boschman TAC (1987) Influence of Factor XIIIa activity on human whole blood clot lysis in vitro. Thromb Haemost 57:171–175
Kasai S, Kunimoto T, Nitta K (1983) Cross-linking of fibrin by activated factor XIII stimulates attachment, morphological changes and proliferation of fibroblasts. Biomed Res 4:155–160
Key M (1983) Macrophages in cancer metastases and their relevance to metastatic growth. Cancer Metastasis Rev 2:75–88
Kradin RL, Lynch GW, Kurnick JT, Erikson M, Colvin RB, McDonagh J (1987) Factor XIII is synthetized and expressed on the surface of U937 cells and alveolar macrophages. Blood 69:778–785
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
Laki K (1974) Fibrinogen and metastases. J Med 5:32–37
Layer GT, Burnand KG, Gaffney PJ, Cederholm-Williams SA, Mahmoud M, Houlbrook S, Pattison M (1987) Tissue Plasminogen activators in breast cancer. Thromb Res 45:601–607
Lorand L, Dickenman RC (1955) Assay method for the “fibrin-stabilizing factor”. Proc Soc Exp Biol 89:45–48
Lorenzet R, Peri G, Locati D, Allavena P, Colucci M, Semeraro N, Mantovani A, Donati MB (1983) Generation of procoagulant activity by mononuclear phagocytes: A possible mechanism contributing to blood clotting activation within malignant tissues. Blood 62:271–273
Muszbek L, Laki K (1984) Interaction of thrombin with proteins other than fibrinogen (thrombin susceptible bonds). Activation of FXIII. In: Machovich R (ed) The thrombin. CRC, Boca Raton, pp 321–342
Muszbek L, Ádány R, Szegedi G, Polgár J, Kávai M (1985) Factor XIII of blood coagulation in human monocytes. Thromb Res 37:401–410
Nicolson GN (1982) Cancer metastasis: Organ colonization and the cell surface properties of malignant cells. Biochim Biophys Acta 695:113–176
Rickles FR, Edwards RL (1983) Activation of blood coagulation in cancer: Trousseau’s syndrome revisited. Blood 62:14–31
Sakata Y, Aoki N (1980) Cross-linking of α2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. J Clin Invest 65:290–297
Sakata Y, Aoki N (1982) Significance of cross-linking of α2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis. J Clin Invest 69:536–542
Ueyama M, Urayama T (1977) The role of factor XIII in fibroblast proliferation. Jpn J Exp Med 48:135–142
VanDeWater L, Tracy PB, Aronson D, Mann KG, Dvorak HF (1985) Tumor cell generation of thrombin via prothrombinase assembly. Cancer Res 45:5521–5525
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Muszbek, L., Ádány, R. (1988). Intratumoral Fibrin Stabilization. In: Nigam, S.K., McBrien, D.C.H., Slater, T.F. (eds) Eicosanoids, Lipid Peroxidation and Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73424-3_36
Download citation
DOI: https://doi.org/10.1007/978-3-642-73424-3_36
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-18932-9
Online ISBN: 978-3-642-73424-3
eBook Packages: Springer Book Archive